About Telura Tenofovir Disoproxil Fumarate Lamivudine Efavirenz Tablets IP
Experience enviable savings and optimum value with Telura Tenofovir Disoproxil Fumarate Lamivudine Efavirenz Tablets IP. This WHO-prequalified, fixed-dose combination therapy is expertly designed for adult patients managing HIV-1 infection. Each gorgeous, yellow, oval, film-coated tablet-embossed with 'M 133'-contains effective doses of Tenofovir, Lamivudine, and Efavirenz for once-daily oral administration. Take advantage of advance purchase offers to secure a 30-tablet pack, ensuring consistent therapy as recommended by a physician. Easily stored below 30C, Telura delivers reliability, quality, and trusted efficacy every day.
Additional Applications and Unique Features
Telura Tenofovir Disoproxil Fumarate Lamivudine Efavirenz Tablets IP is specifically intended for the treatment of HIV infection in adults, providing an optimum therapeutic regime for antiretroviral therapy. The tablet's solid oral form and attractive film coating ensure ease of swallowing, while its fixed-dose combination supports treatment compliance. Ideal for clinical, hospital, and outpatient settings, the site of application remains oral for systemic benefit. Embossed markings and secure packaging guarantee authenticity and peace of mind.
Export Markets, Domestic Presence, and Certifications
Telura is widely recognized and trusted in both main export markets and local Indian markets, supported by WHO prequalification and robust regulatory compliance. With quick dispatch and comprehensive logistics solutions, Telura reaches healthcare providers swiftly at competitive rates. The product's packaging, which includes barcode identification, ensures seamless tracking across supply chains. These stringent standards make it a preferred choice for suppliers, exporters, and traders around the world.
FAQ's of Telura Tenofovir Disoproxil Fumarate Lamivudine Efavirenz Tablets IP:
Q: How should Telura Tenofovir Disoproxil Fumarate Lamivudine Efavirenz Tablets IP be taken?
A: Telura Tablets should be taken orally once daily, exactly as prescribed by a healthcare professional. Swallow the tablet whole with water, preferably at the same time each day to maintain optimum medication levels.
Q: What are the main benefits of choosing Telura for HIV-1 infection treatment?
A: Telura offers a gorgeous fixed-dose combination of three potent antiretroviral agents in one tablet, enhancing treatment convenience and compliance for adults with HIV-1 infection. WHO prequalification and embossed security features guarantee enviable quality and authenticity.
Q: Where is Telura primarily exported and used?
A: Telura is exported to various international markets and widely distributed within India. Its logistics infrastructure enables quick dispatch to healthcare providers, suppliers, and service providers globally and domestically.
Q: What process ensures Telura's authenticity and regulatory compliance?
A: Telura comes with a box barcode and distinct tablet imprint (M 133, embossed) to confirm authenticity. It is WHO prequalified and manufactured under stringent regulatory standards to ensure safety and effectiveness.
Q: When is the best time to purchase Telura for optimum savings?
A: Take advantage of advance purchase offers and bulk orders from authorized suppliers or traders to maximize your savings and maintain a consistent treatment supply.